Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Hepatocellular 42 Parkinson Disease 4, Autosomal Dominant Lewy Body 29 Carcinoma, Renal Cell 26 Endometrial Neoplasms 13 Melanoma 10 Neoplasms 8 Uterine Cervical Neoplasms 7 Cholangiocarcinoma 7 Biliary Tract Neoplasms 7 Liver Neoplasms 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Neuroendocrine Tumors 5 Triple Negative Breast Neoplasms 4 Thyroid Neoplasms 4 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Esophageal Squamous Cell Carcinoma 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Thyroid Carcinoma, Anaplastic 3 Recurrence 3 Kidney Neoplasms 3 Esophageal Neoplasms 3 Diabetes Mellitus, Insulin-Dependent, 12 3 Carcinoma, Adenoid Cystic 3 Breast Neoplasms 3 Brain Neoplasms 3 Adenocarcinoma 3 Vulvar Neoplasms 2

Interventions

Cyclophosphamide 31 fludarabine 28 Whole-Body Irradiation 18 Mycophenolic Acid 18 venetoclax 14 Tacrolimus 14 fludarabine phosphate 13 Standard of Care 13 Specimen Handling 10 Practice Guidelines as Topic 10 Melphalan 10 Busulfan 10 Sirolimus 9 Thiotepa 8 Interviews as Topic 8 Azacitidine 8 Educational Status 7 trametinib 6 Surveys and Questionnaires 6 Methods 6 Mesna 6 Biopsy 6 thymoglobulin 5 Rituximab 5 Magnetic Resonance Spectroscopy 5 Filgrastim 5 Early Intervention, Educational 5 Behavior Therapy 5 Antilymphocyte Serum 5 Peripheral Blood Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Neoplasms × lenvatinib × 1 year × Clear all

NCT03486873 2026-06-05

MK-3475-587

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡